Western blot results suggested that Bufalin decreased the expression of stemness-associated surface proteins CD133 and CD44, and stemness-associated factors Sox2 and Oct4, which further illustrated that Bufalin has the inhibitory effect on gallbladder cancer stem cells. Here, CD44 is linked to gallbladder cancer.